These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10672449)

  • 1. The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective.
    Palmer AJ; Weiss C; Sendi PP; Neeser K; Brandt A; Singh G; Wenzel H; Spinas GA
    Diabetologia; 2000 Jan; 43(1):13-26. PubMed ID: 10672449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCCT: implications for diabetes care in the UK.
    Boulton AJ
    Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreas, diabetes mellitus and pancreatic transplantation--a retrospective survey.
    Adeghate E; Donáth T
    Acta Chir Hung; 1998; 37(1-2):133-51. PubMed ID: 10196623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and complicated diabetes.
    Pearson JF
    Br J Hosp Med; 1993 May 19-Jun 1; 49(10):739-42. PubMed ID: 8324597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany.
    Adarkwah CC; Gandjour A
    Int J Technol Assess Health Care; 2010 Jan; 26(1):62-70. PubMed ID: 20059782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular and macrovascular complications associated with diabetes in children and adolescents.
    Donaghue KC; Chiarelli F; Trotta D; Allgrove J; Dahl-Jorgensen K
    Pediatr Diabetes; 2009 Sep; 10 Suppl 12():195-203. PubMed ID: 19754630
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial.
    Eastman RC; Leptien AD; Chase HP
    Pediatr Diabetes; 2003 Jun; 4(2):82-6. PubMed ID: 14655264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes II: Can good control prevent degenerative complications of juvenile diabetes mellitus?
    Marr TJ; Traisman HS; Traisman ES
    J Kans Med Soc; 1982 Jun; 83(6):291-4. PubMed ID: 7108335
    [No Abstract]   [Full Text] [Related]  

  • 11. [Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark].
    Palmer AJ; Lammert M; Hermansen K
    Ugeskr Laeger; 2008 Apr; 170(15):1250-4. PubMed ID: 18433583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy.
    Parving HH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612
    [No Abstract]   [Full Text] [Related]  

  • 13. A simulation model of the cost of the incidence of IDDM in Spain.
    Hart WM; Espinosa C; Rovira J
    Diabetologia; 1997 Mar; 40(3):311-8. PubMed ID: 9084970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How Germany manages it's diabetic patients].
    Einecke D
    MMW Fortschr Med; 1999 Oct; 141(42):4-5. PubMed ID: 10912093
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic renal-retinal syndrome: does tight control help?
    Cowan CL
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):86-9. PubMed ID: 3551259
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delayed diabetic syndrome in type I insulin-dependent diabetes].
    Pou Torelló JM
    An Esp Pediatr; 1992; 37 Suppl 51():29-33. PubMed ID: 1492723
    [No Abstract]   [Full Text] [Related]  

  • 17. Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model.
    Tomar RH; Lee S; Wu SY; Klein R; Klein BE; Moss SE; Fryback DG; Tollios JL; Sainfort F
    J Soc Health Syst; 1998; 5(4):24-37. PubMed ID: 9785295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nephropathy and lipid disorders. Making progress while heeding Molière's warning.
    Bloomgarden ZT
    Diabetes Care; 1994 Aug; 17(8):946-8. PubMed ID: 7956651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.